4//SEC Filing
SQUINTO STEPHEN P 4
Accession 0001209191-20-014671
CIK 0001787297other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:42 PM ET
Size
8.1 KB
Accession
0001209191-20-014671
Insider Transaction Report
Form 4
SQUINTO STEPHEN P
DirectorHead of Research and Dev
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-02-27+185,776→ 185,776 totalExercise: $18.00Exp: 2030-02-27→ Common Stock (185,776 underlying) - Award
Director Stock Option (Right to Buy)
2020-02-27+33,836→ 33,836 totalExercise: $18.00Exp: 2030-02-27→ Common Stock (33,836 underlying)
Footnotes (2)
- [F1]The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F2]The option vest as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
Passage BIO, Inc.
CIK 0001787297
Entity typeother
Related Parties
1- filerCIK 0001231954
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:42 PM ET
- Size
- 8.1 KB